BlueStone Venture Partners, LLC
bluestonevp.com
Financial Services
Venture Capital
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
December 11, 2019 — in BlueStone News BlueStone Managing Director Mara Aspinall named to 2019 Most Influential Corporate Directors List by WomenInc. Magazine Brentwood, Tennessee –BlueStone Managing Director, Mara Aspinall, today was named to WomenInc.
News
Elucid's PlaqueIQ Image Analysis Software Now Covered by United Healthcare
Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, announced that United Healthcare has updated its cardiac imaging guidelines to fully alig
Read more
Report
GT Medical closes $53M round to commercialize brain tumor device
GammaTile consists of radioactive sources embedded in a collagen matrix. Placed in the cavity created by the removal of a brain tumor, the device delivers radiation therapy to eliminate any cancer cells that are still in the area after surgery. The Food a
Read more
Report
Akadeum secures $20m to advance cell separation platform
Biotechnology firm Akadeum Life Sciences announced the closing of a $20 million financing round that will enable the company to advance its CGT product suite. Michigan Capital Network led the investment alongside contributions from Arboretum Ventures, NYB
Read more
Report
Pyx Health acquires FarmboxRx to expand its reach tackling social health needs and food insecurity
Companies that address individuals' nonmedical social needs such as food insecurity, transportation, isolation and loneliness, are carving out a place in the healthcare market. Many of these companies work with health plans to serve hard-to-reach, vulnera
Read more
Report
New Mexico's NTx Bio To Build $31M Biomanufacturing Facility in North Texas
Rio Rancho, New Mexico-based NTx Bio will establish a biomanufacturing facility in Plano, creating more than 170 new jobs and more than $31 million in capital investment, Gov. Greg Abbott announced. A Texas Enterprise Fund (TEF) grant of nearly $1.5 milli
Read more
Report
CND Life Sciences Closes $13.5M Series A Equity Round to Continue Growth and Innovation in Neurodiagnostics
Read more
Report
Hannah Storm, Award-Winning Broadcaster and DCIS Patient Advocate, Partners with PreludeDx to Share How the DCISionRT Test Gave Her Confidence in Her Treatment Decision
LAGUNA HILLS, Calif., Feb. 12, 2025 /PRNewswire/ - Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer, today announced a partnership with Hannah Storm, an Emmy award-winning sports broadcaster, producer and di
Read more
Report
PreludeDx Receives FDA Breakthrough Device Designation for DCISionRT Test for DCIS Breast Cancer Patients
LAGUNA HILLS, Calif., Jan. 16, 2025 /PRNewswire/ - Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device designation f
Read more
Report
GT Medical Technologies Raises $37 Million in Series D to Advance the Expansion of GammaTile in the U.S. for Patients with Operable Brain Tumors
Read more
Report
NTx Announces Full Commercial Availability of NTxscribe to Broadly Enable RNA Therapies
RIO RANCHO, N.M., January 09, 2025-(BUSINESS WIRE)-Nature's Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the full commercial availability of NTxscribe, a benchtop, continuou
Read more
Report